IVUS + NIRS: The PROSPECT II Study Published on The Lancet

11 March 2021

The PROSPECT II Study has been published in the current issue of The Lancet.

 

Study findings show that combined #NIRS and #IVUS detects angiographically non-obstructive lesions with a high lipid content and large plaque burden that are at increased risk for future adverse cardiac outcomes.

 

Click  The PROSPECT II Study to read more

 

Latest News:

It continues the interview series to experts on "The Vulnerable Patient"

In this interview Dr Simone Biscaglia, S. Anna University in…

Read More >

EUKON and M.A.C. Healthcare Cybersecurity

Caserta, ITALY – September 8th, 2021 —  EUKON’ experience in…

Read More >

Multicenter clinical evaluation of a piezoresistive-MEMSsensor rapid-exchange pressure microcatheter system for fractional flow reserve measurement-2021

  Multicenter-clinical-evaluation-of-a-piezoresistive-MEMSsensor-rapid-exchange-pressure-microcatheter-system-for-fractional-flow-reserve-measurement-2021.pdf This multicenter, prospective clinical study investigates whether the…

Read More >